Search

Peter M Meserol

Deceased

from Montville, NJ

Peter Meserol Phones & Addresses

  • 12 Stoneybrook Rd, Montville, NJ 07045
  • 228 Hurd St, Mine Hill, NJ 07803
  • Wharton, NJ
  • Boonton, NJ

Us Patents

  • Electrodes Having A Continuous, Crystalline Metal Nitride Coating And Method Of Use

    view source
  • US Patent:
    6485961, Nov 26, 2002
  • Filed:
    Jul 18, 2000
  • Appl. No.:
    09/618654
  • Inventors:
    Peter Meserol - Montville NJ
  • Assignee:
    MaxCyte, Inc. - Rockville MD
  • International Classification:
    C12M 300
  • US Classification:
    4352852, 4351736, 20429012, 20429013
  • Abstract:
    An improved electrode for use in generating an electrical field in a saline solution is provided. In particular, a continuous crystalline metal nitride coated electrode is provided for use in a variety of saline solution applications, such as in an electrophoresis device for separating proteins or nucleic acids or an electroporation apparatus for the encapsulation of biologically-active substances in various cell populations. A method and apparatus are provided for the encapsulation of biologically-active substances in red blood cells, characterized by an optionally automated, continuous-flow, self-contained electroporation system which allows withdrawal of blood from a patient, separation of red blood cells, encapsulation of a biologically-active substances in the cells, and optional recombination of blood plasma and the modified red blood cells thereby producing blood with modified biological characteristics.
  • Electroporation Chamber Including An Electrode Having A Continuous, Crystalline Metal Nitride Coating

    view source
  • US Patent:
    6617154, Sep 9, 2003
  • Filed:
    Nov 8, 2000
  • Appl. No.:
    09/707931
  • Inventors:
    Peter Meserol - Montville NJ
  • Assignee:
    MaxCyte, Inc. - Rockville MD
  • International Classification:
    C12M 300
  • US Classification:
    4352852, 4351736, 20429012, 20429013
  • Abstract:
    An improved electrode for use in generating an electrical field in a saline solution is provided. In particular, a continuous crystalline metal nitride coated electrode is provided for use in a variety of saline solution applications, such as in an electrophoresis device for separating proteins or nucleic acids or an electroporation apparatus for the encapsulation of biologically-active substances in various cell populations. A method and apparatus are provided for the encapsulation of biologically-active substances in red blood cells, characterized by an optionally automated, continuous-flow, self-contained electroporation system which allows withdrawal of blood from a patient, separation of red blood cells, encapsulation of a biologically-active substances in the cells, and optional recombination of blood plasma and the modified red blood cells thereby producing blood with modified biological characteristics.
  • Flow Electroporation Chamber And Method

    view source
  • US Patent:
    6773669, Aug 10, 2004
  • Filed:
    Nov 8, 2000
  • Appl. No.:
    09/707928
  • Inventors:
    John W. Holaday - Bethesda MD
    Peter H. Meserol - Montville NJ
    Doug Doerfler - Darnestown MD
    Shawn J. Green - Vienna VA
    Vininder Singh - Gaithersburg MD
  • Assignee:
    Maxcyte, Inc. - Rockville MD
  • International Classification:
    C12N 1587
  • US Classification:
    422 44, 422 33, 4351736
  • Abstract:
    The present invention relates to a method and apparatus for the encapsulation of substances and drugs into cells and platelets. The present invention is also related to the incorporation of thrombus dissolving drugs, such as tissue plasminogen activator and streptokinase into platelets using the apparatus described herein. The treated platelets can then be used to treat patients suffering from a thrombus blocking a blood vessel. The present invention is also related to a preparation of red blood cells that has a stable right shift of the oxygen dissociation curve.
  • Biological Fluid Analysis Device

    view source
  • US Patent:
    20020072084, Jun 13, 2002
  • Filed:
    Apr 6, 2001
  • Appl. No.:
    09/827142
  • Inventors:
    Peter Meserol - Montville NJ, US
    Frank Pascale - Glen Cove NY, US
    Barry Wenz - Bedford NY, US
  • International Classification:
    C12Q001/66
    C12Q001/32
    G01F001/64
  • US Classification:
    435/026000, 435/287100, 205/778000
  • Abstract:
    A biological fluid analysis device including a biosensor is disclosed.
  • Medical Management System And Method

    view source
  • US Patent:
    20030229517, Dec 11, 2003
  • Filed:
    Mar 11, 2003
  • Appl. No.:
    10/386271
  • Inventors:
    Peter Meserol - Montville NJ, US
    Jerry Slaven - Hillsborough NJ, US
    T. Madison - Skillman NJ, US
  • International Classification:
    G06F017/60
    A61B005/00
  • US Classification:
    705/002000, 705/007000, 600/300000
  • Abstract:
    A system and method is provided wherein managed care organizations (MCO) are invoiced directly by an entity which provides reports and/or data to the patient, to the patient's healthcare provider and to the patient's MCO, on a periodic basis. The reports are based on patient glucose or other disease monitoring tests inputted to a patient test analyzer monitor uniquely identified to the patient. The monitor is programmed to communicate over telephone lines or other communication system to the entity as frequently as nightly each day's tests with time and date stamps for each test. The entity optionally causes test units to be shipped directly to the patient as needed by monitoring patient supplies through the transmitted tests. Test results are correlated in reports to each patient and his or her healthcare provider and MCO. The reports provide timely information as to the status of the patient's control of the disease and results in timely provided therapy to the patient based on such current reporting, encouraging compliance by the patient. The MCO is billed periodically by the entity for the reports and all test units, if any, eliminating middlemen and improving administrative efficiency.
  • Biological Fluid Analysis Device

    view source
  • US Patent:
    20040014023, Jan 22, 2004
  • Filed:
    Apr 23, 2003
  • Appl. No.:
    10/415035
  • Inventors:
    Peter Meserol - Montville NJ, US
    Frank Pascale - Glen Cove NY, US
    Barry Wenz - Bedford NY, US
  • International Classification:
    A01N001/02
  • US Classification:
    435/002000
  • Abstract:
    A biological fluid analysis device () including a biosensor () comprising an electrochemical-enzymatic sensor including a working electrode () and a reference electrode (), is disclosed.
  • Photodynamic Biological Fluid Pathogen Inactivation/Filtering Apparatus And Method

    view source
  • US Patent:
    20040256329, Dec 23, 2004
  • Filed:
    Jun 8, 2004
  • Appl. No.:
    10/863163
  • Inventors:
    Peter Meserol - Mine Hill NJ, US
    Jesse Acker - Hackettstown NJ, US
    Rita Prodell - West Orange NJ, US
    Lawrence Lenart - Clifton NJ, US
    Robert Schenck - East Rutherford NJ, US
    Shirley Meserol - Mine Hill NJ, US
  • International Classification:
    C02F001/30
  • US Classification:
    210/748000, 210/205000
  • Abstract:
    A tube has a plurality of sections, several with a transparent wall and a static mixer in each section, which mixers may also be transparent. The initial section mixes a photo inactivation agent with a body fluid such as blood and so on. The static mixers each have adjacent static mixing elements including a pair of axially aligned static mixing sections each formed of a 180 helix, adjacent sections being relatively rotated 90, all of the elements being aligned in a corresponding tube section and having the same orientation. The apparatus is disposable and includes fluid supply containers, tubing, valves, sensors, and mixing devices coupled to pumps, all under control of a CPU. A static mixer filter filters the processed fluid and may contain porous resin particles coated on the inner surfaces of or packed into a mixing device, and/or coated on a porous membrane in a mixing device. Light is supplied by high power LEDs which may include cooling devices and reflectors for photo inactivation of the agent.
  • Flow Electroporation Chamber And Method

    view source
  • US Patent:
    20050019311, Jan 27, 2005
  • Filed:
    May 14, 2004
  • Appl. No.:
    10/846729
  • Inventors:
    John Holaday - Bethesda MD, US
    Peter Meserol - Montville NJ, US
    Doug Doerfler - Darnestown MD, US
    Shawn Green - Vienna VA, US
    Vininder Singh - Gaithersburg MD, US
  • International Classification:
    A61K045/00
    C12N005/08
  • US Classification:
    424093700, 435372000
  • Abstract:
    The present invention relates to a method and apparatus for the encapsulation of substances and drugs into cells and platelets. The present invention is also related to the incorporation of thrombus dissolving drugs, such as tissue plasminogen activator and streptokinase into platelets using the apparatus described herein. The treated platelets can then be used to treat patients suffering from a thrombus blocking a blood vessel. The present invention is also related to a preparation of red blood cells that has a stable right shift of the oxygen dissociation curve.

Get Report for Peter M Meserol from Montville, NJDeceased
Control profile